Home Stocks SOPH Sophia Genetics SA (NASDAQ: SOPH) Healthcare · Health Information Services
$7.47 +0.02 (+0.27%)
Last close · Nov 18, 2026 · NASDAQ USD
The Quantellect read. SOPH rose 0.27% in the Nov 18 session to $7.47. The borrow fee is 4.45%. Three active firms cover the stock as of Nov 19, 2026; three active firms with targets average $10.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.
Momentum Neutral RSI (14) 55.5 (overbought above 70, oversold below 30)
Short interest 1.8% of float FINRA settlement Oct 30, 2026
SMA 10 — SMA 20 — SMA 50 — SMA 200 —
Price details unavailable for this range. ×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date — Last date — Open — High — Low — Close — Volume — Plotted bars 0
Plotted OHLCV bars No price bars are available for this range.
Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of —
Initial 6M price range summary Range 6M First close — Last close — High — Low — Volume —
Open $7.46 Nov 18, 2026 session
Previous close $7.45 Nov 17, 2026 close
Day range $7.31 – $7.85 Nov 18, 2026 session
52-week range —
Volume 607.30K Nov 18, 2026 session
Average volume (30 calendar days) —
Market cap —
P/E (TTM) —
Forward P/E —
EPS (TTM) —
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) —
Price history SOPH · NASDAQ · USD
Split-adjusted · volume in shares
Price history unavailable Retry
Notable price movement — · Notable price movement not available
Options flow — · Options flow not available
Q Score — · Q Score not available
Industry comparison — · Industry comparison not available
Upcoming events — · Upcoming events not available
Analyst consensus Buy
0 Strong Buy
3 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 3 active firms as of Nov 19, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $7.00
Average $10.00
High $14.00
As of Nov 19, 2026 across 3 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast → Earnings history — · Earnings history not available
Smart-money activity In the last 60 days: 21 insider sales and 2 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.
Date Type Who Action Amount Source
Nov 16, 2026 Insider sell Van Well Daan Sell $9.5K Form 4 Nov 12, 2026 Insider sell Menu Philippe Sell $38.4K Form 4 Nov 10, 2026 Insider sell HIBBS KATHY L Sell $48.5K Form 4 Nov 10, 2026 Insider sell Camblong Jurgi Sell $65.9K Form 4 Nov 9, 2026 Insider sell Van Well Daan Sell $10.5K Form 4 Nov 6, 2026 Insider buy CARDOZA GEORGE Buy $141.2K Form 4 Nov 6, 2026 Insider buy Muken Ross Buy $137.2K Form 4 Oct 12, 2026 Insider sell Menu Philippe Sell $36.3K Form 4 All smart-money activity →
News and press releases News and press releases are not available.
All SOPH news → Company profile SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in
CEO Mr. Ross Jordan Muken B.Sc.
Headquarters Rolle, Switzerland
Employees 415
IPO date Jul 23, 2021
Sector Healthcare
Industry Health Information Services Q Score — · Q Score not available
Upcoming events — · Upcoming events not available
Analyst consensus Buy
0 Strong Buy
3 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 3 active firms as of Nov 19, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $7.00
Average $10.00
High $14.00
As of Nov 19, 2026 across 3 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast → Earnings history — · Earnings history not available
Company profile SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in
CEO Mr. Ross Jordan Muken B.Sc.
Headquarters Rolle, Switzerland
Employees 415
IPO date Jul 23, 2021
Sector Healthcare
Industry Health Information Services